Rapid hematopoietic recovery after multicycle high-dose chemotherapy: Enhancement of filgrastim-induced progenitor-cell mobilization by recombinant human stem-cell factor

Journal of Clinical Oncology

Volumn 16, Issue 5, 1998, Pages 1899-1908

  Basser, Russell L ^a   Bik To, L ^a   Glenn Begley, C ^a   Maher, Darryl ^a   Juttner, Christopher ^a   Cebon, Jonathan ^a   Mansfield, Rachel ^a   Olver, Jan ^a   Duggan, Geraint ^a   Szer, Jeffrey ^a   Collins, John ^a   Schwartz, Bernadette ^a   Marty, Jennifer ^a   Menchaca, Dora ^a   Sheridan, William P ^a   Fox, Richard M ^a   Green, Michael D ^a  

^a ROYAL MELBOURNE HOSPITAL   (Australia)

Author keywords

[No Author keywords available]

Indexed keywords

CYCLOPHOSPHAMIDE; EPIRUBICIN; MESNA; RECOMBINANT GRANULOCYTE COLONY STIMULATING FACTOR; RECOMBINANT STEM CELL FACTOR;

ADULT; ANGIONEUROTIC EDEMA; APHERESIS; ARTICLE; BLOOD TOXICITY; BREAST CANCER; CANCER CHEMOTHERAPY; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DRUG EFFICACY; DRUG MEGADOSE; DRUG SAFETY; FEMALE; FEVER; HEMATOPOIESIS; HUMAN; HYPOTENSION; INTRAVENOUS DRUG ADMINISTRATION; MAJOR CLINICAL STUDY; NAUSEA; PERIPHERAL BLOOD STEM CELL; PRIORITY JOURNAL; PRURITUS; RANDOMIZED CONTROLLED TRIAL; SUBCUTANEOUS DRUG ADMINISTRATION; URTICARIA;

EID: 0031859858     PISSN: 0732183X     EISSN: None     Source Type: Journal    
DOI: 10.1200/JCO.1998.16.5.1899     Document Type: Article

References (55)

1. Tannock IF, Boyd NF, DeBoer G, et al.: A randomized trial of two dose levels of cyclophosphamide, methotrexate, and fluorouracil chemotherapy for patients with metastatic breast cancer. J Clin Oncol 6:1377-1387, 1988
2. Wood WC, Budman DR, Korzus AH, et al.: Dose and dose-intensity of adjuvant chemotherapy for stage II, node-positive breast carcinoma. N EngI J Med 330:1253-1259, 1994
3. Bonadonna G, Valagussa P, Moliterni A, et al.: Adjuvant cyclophosphamide, methotrexate, and fluorouracil in node-positive breast cancer - The results of 20 years of follow-up. N Engl J Med 332:901-906, 1995
4. Eddy DM: High-dose chemotherapy with autologous bone marrow transplantation for the treatment of metastatic breast cancer. J Clin Oncol 10:657-670,1992
5. Bezwoda WR, Seymour L, Dansey RD: High-dose chemotherapy with hematopoietic rescue as primary treatment for metastatic breast cancer: A randomized trial. J Clin Oncol 13:2483-2489, 1995
6. Amman KH, Rowlings PA, Vaughan WP, et al.: High-dose chemotherapy with autologous hematopoietic stem-cell support for breast cancer in North America. J Clin Oncol 15:1870-1879, 1997
7. DeVita VT Principles of chemotherapy, in DeVita VT Jr, Hellman S, Rosenberg SA (eds): Cancer: Principles and Practice of Oncology, (ed 4). Philadelphia, PA, Lippincott, 1993, pp 276-292
8. Duhrsen U, Villeval JL, Boyd J, et al.: Effects of recombinant granulocyte colony-stimulating factor on hematopoietic progenitor cells in cancer patients. Blood 72:2074-2081, 1988
9. De Luca E, Sheridan WP, Watson D, et al.: Prior chemotherapy does not prevent effective mobilisation by G-CSF of peripheral blood progenitor cells. Br J Cancer 66:893-899, 1992
10. Grigg AP, Roberts AW, Raunow H, et al.: Optimizing dose and scheduling of filgrastim (granulocyte colony-stimulating factor) for mobilization and collection of peripheral blood progenitor cells in normal volunteers. Blood 86:4437-4445,1995
11. Sheridan WP, Begley CG, Juttner ÇA, et al.: Effect of peripheral-blood progenitor cells mobilised by filgrastim (G-CSF) on platelet recovery after high-dose chemotherapy. Lancet 339:640-644, 1992
12. Sheridan WP, Begley CG, To LE, et al.: Phase study of autologous filgrastim-mobilized peripheral blood progenitor cells to restore hemopoiesis after high-dose chemotherapy for lymphoid malignancies. Bone Marrow Transplant 14:105-111, 1994
13. Basser RL, To BL, Begley CG, et al.: Adjuvant treatment of high-risk breast cancer using multicycle high-dose chemotherapy and filgrastim-mobilized peripheral blood progenitor cells. Clin Cancer Res 1:715-721,1995
14. To LB, Haylock DN, Simmons PJ, et al.: The biology and clinical uses of blood stem cells. Blood 89:2233-2258, 1997
15. Tsai M, Takeishi T, Thompson H, et al.: Induction of mast cell proliferation, maturation, and heparin synthesis by the rat c-kit ligand, stem cell factor. Proc NatI Acad Sci U S A 88:6382-6386,1991
16. Ulich TR, Del Castillo J, Yi ES, et al.: Hématologie effects of stem cell factor in vivo and in vitro in rodents. Blood 78:645-650, 1991
17. Andrews RG, Knitter GH, Bartelmez SH, et al.: Recombinant human stem cell factor, a c-kit ligand, stimulates hematopoiesis in primates. Blood 78:1975-1980, 1991
18. Molineux G, Migdalska A, Szmitkowski M, et al.: The effects on hematopoiesis of recombinant stem cell factor (ligand for c-kit) administered in vivo to mice either alone or in combination with granulocyte colony-stimulating factor. Blood 78:961-966,1991
19. McNiece IK, Langley KE, Zsebo KM: Recombinant human stem cell factor synergizes with GM-CSF, G-CSF, IL-3 and EPO to stimulate human progenitor cells of the myeloid and erythroid lineages. Exp Hematol 19:226-231,1991
20. Briddell RA, Hartley CA, Smith KA, et al.: Recombinant rat stem cell factor synergizes with recombinant human granulocyte colony-stimulating factor in vivo in mice to mobilize peripheral blood progenitor cells that have enhanced repopulating potential. Blood 82:1720-1723, 1993
21. Van X-Q, Briddell R, Hartley C, et al.: Mobilization of long-term hematopoietic reconstituting cells in mice by the combination of stem cell factor and granulocyte colony-stimulating factor. Blood 84:795-799,1994
22. de Revel T, Appelbaum FR, Storb R, et al.: Effects of granulocyte colony-stimulating factor and stem cell factor, alone and in combination, on the mobilization of peripheral blood cells that engraft lethally irradiated dogs. Blood 83:3795-3799, 1994
23. Andrews RG, Briddell RA, Knitter GH, et al.: Rapid engraftment by peripheral blood progenitor cells mobilized by recombinant human stem cell factor and recombinant human granulocyte colony-stimulating factor in nonhuman primates. Blood 85:15-20,1995
24. Andrews RG, Briddell RA, Knitter GH, et al.: In vivo synergy between recombinant human stem cell factor and recombinant human granulocyte colony-stimulating factor in baboons: Enhanced circulation of progenitor cells. Blood 84:800-810,1994
25. Kurtzberg J, Meyers F, McGuire B, et al.: Mobilization of peripheral blood progenitor cells in patients given recombinant methionyl stem cell factor. Proc Am Assoc Cancer Res 34:211, 1993 (abstr)
26. Demetri GD, Gordon M, Hoffman R, et al.: Effects of recombinant methionyl human stem cell factor on hematopoietic progenitor cells in vivo: Preliminary results from a phase I trial. Proc Am Assoc Cancer Res 34:217,1993 (abstr)
27. Sheridan WP, Morstyn G, Wolf M, et al.: Granulocyte colony-stimulating factor (G-CSF) and neutrophil recovery following high-dose chemotherapy and autologous bone marrow transplantation. Lancet 2:891-895,1989
28. Begley CG, Basser R, Mansfield R, et al.: Enhanced levels and clonogenic capacity of blood progenitor cells following administration of stem cell factor and filgrastim to humans. Blood 90:3378-3389,1997
29. + cells mobilized by four different protocols and those of steady-phase PB and bone marrow CD34+ cells. Blood 84:2930-2939,1994
30. Schmilz N, Linch DC, Dreger P, et al.: Randomised trial of filgrastim-mobilized peripheral blood progenitor cell transplantation versus autologous bone marrow transplantation in lymphoma patients. Lancet 347:353-357, 1996
31. Glaspy JA, Shpall EJ, LeMaistre CF, et al.: Peripheral blood progenitor cell mobilization using stem cell factor in combination with filgrastim in breast cancer patients. Blood 90:2939-2951,1997
32. Moskowitz CH, Stiff P, Gordon MS, et al.: Recombinant methionyl human stem cell factor and filgrastim for peripheral blood progenitor cell mobilization and transplantation in non-Hodgkin's lymphoma patients-Results of a phase I/trial. Blood 89:3136-3147,1997
33. Rasko JEJ, Basser RL, Boyd J, et al.: Multilineage mobilization of peripheral blood progenitor cells in humans following administration of PEG-rHuMGDF. Br J Haematol 97:871-880,1997
34. Basser R, DeBoer R, Mitchell P, et al.: Randomized study of megakaryocyte growth and development factor (PEG-rHuMGDF) before and after chemotherapy. Influence of schedule on clinical effect: Early results. Pro Am Soc Clin Oncol 16:120A, 1997 (abstr)
35. Laterveer L, Lindley IJD, Heemskerk DPM, et al.: Rapid mobilization of hematopoietic progenitor cells in rhesus monkeys by a single intravenous injection of interleukin-8. Blood 87:781-788, 1996
36. Roberts AW, DeLuca E, Begley CG, et ai: Broad interindividual variations in circulating progenitor cell numbers induced by granulocyte colony-stimulating factor therapy. Stem Cells 13:512-516,1995
37. Oostendorp RAJ, Reisbach G, Spitzer E, et al.: VLA-4 and VCAM-1 are the principal adhesion molecules involved in the interaction between blast colony-forming cells and bone marrow stromal cells. BrJ Haematol 91:275-284,1995
38. Papayannopoulou T, Nakamoto B: Peripheralization of hemopoietic progenitors in primates treated with anti-VLA4 integrin. Proc Natl Acad Sci U S A 90:9374-9378, 1993
39. Kodama H, Nose M, Niida S, et al.: Involvement of the c-kit receptor in the adhesion of hematopoietic stem cells to stromal cells. Exp Hematol 22:979-984, 1994
40. Simmons PJ, Leavesley DI, Levesque JP, et al.: The mobilization of primitive hemopoietic progenitors into the peripheral blood. Stem Cells Day 112:187-201,1994(suppl 1)
41. Cynshi O, Satoh K, Shimonaka Y, et al.: Reduced response to granulocyte colony-stimulating factor in VAVV and SI/SIJ mice. Leukemia 5:75-77, 1991
42. Okumura N, Tsuji K, Ebiharo Y, et al.: Chemotactic and chemokinetic activities of stem cell factor on murine hematopoietic progenitor cells. Blood 87:4100-4108,1996
43. Krause DS, Fackler MJ, Civin CI, et al.: CD34: Structure, biology, and clinical utility. Blood 87:1-13,1996
44. Crawford J, Lau D, Erwin R, et al.: A phase I trial of recombinant methionyl human stem cell factor (SCF) in patients with advanced non-small-cell lung cancer. Proc Am Soc Clin Oncol 12:135, 1993 (abstr)
45. Demetri G, Costa J, Hayes D, et al.: A phase I trial of recombinant methionyl human stem cell factor (SCF) in patients with advanced breast carcinoma pre- and postchemotherapy (chemo) with cyclophosphamide (C) and doxorubicin (A). Proc Am Soc Clin Oncol 12:412, 1993 (abstr)
46. Pettengell R, Morgenstern GR, Woll PJ, et al.: Peripheral blood progenitor cell transplantation in lymphoma and leukemia using a single apheresis. Blood 82:3770-3777,1993
47. Jones HM, Jones SA, Watts MJ, et al.: Development of a simplified single-apheresis approach for peripheral-blood progenitorcell transplantation in previously treated patients with lymphoma. J Clin Oncol 12:1693-1702,1994
48. Pettengell R, Woll PJ, Thatcher N, et al.: Multicyclic, dose-intensive chemotherapy supported by sequential reinfusion of hematopoietic progenitors in whole blood. J Clin Oncol 13:148-156,1995
49. Tricot G, Jagannath S, Desikan KR, et al.: Superior mobilization of peripheral blood progenitor cells (PBPC) with r-metHu SCF and r-metHu G-CSF (filgrastim) in heavily pretreated multiple myeloma (MM) patients. Blood 88:388A, 1996 (suppl 1, abstr)
50. Bensinger WI, Buckner CD, Shannon-Dorcy K, et al.: Transplantation of allogeneic CD34+ peripheral blood stem cells in patients with advanced hematologic malignancy. Blood 88:4132-4138, 1996
51. Pavletic ZS, Bishop MR, Tarantolo SR, et al.: Hematopoietic recovery after allogeneic blood stem-cell transplantation compared with bone marrow transplantation in patients with hematologic malignancies. J Clin Oncol 15:1608-1616,1997
52. Sudo Y, Shimazaki C, Ashihara E, et al.: Synergistic effect of FLT-3 ligand on the granulocyte colony-stimulating factor-induced mobilization of hematopoietic stem cells and progenitor cells into blood in mice. Blood 89:3186-3191, 1997
53. Basser RL, Rasko JEJ, Clarke K, et al.: Thrombopoietic effects of pegylated recombinant human megakaryocyte growth and development factor (PEG-rHuMGDF) in patients with advanced cancer. Lancet 348:1279-1281, 1996
54. Basser RL, Rasko JEJ, Clarke K, et al.: Randomized, blinded, placebo-controlled phase I trial of pegylated recombinant human megakaryocyte growth and development factor (PEG-rHuMGDF) with filgrastim after dose-intensive chemotherapy in patients with advanced cancer. Blood 89:3118-3128, 1997
55. Uharek L, Härtung G, Zeis M, et al.: Superior graft-versus-leukemia activity after transplantation of peripheral blood progenitor cell (PBPC) grafts mobilized by G-CSF and SCF compared to G-CSF alone. Exp Hematol 25:788, 1997 (suppl, abstr)